Webinar | July 28, 2022

Get Your Therapies To Market Faster With Quick And Accurate Testing For Lentivirus And AAVs

Source: bio-techne

Modern medicines call for modern technologies. Revolutionary cell and gene therapies offer significant promise to treat life-threatening diseases. Getting therapies to market quickly and efficiently requires accurate testing of critical quality attributes, including accurate viral vector analysis. Today’s cell and gene therapies leverage two key viral vectors: Lentivirus vectors (LVV) and adeno-associated virus (AAV).

In this technical seminar, you will learn how Simple Western by Bio-Techne can improve your vector analytics. Simple Western instruments are multi-attribute machines for both lentivirus and AAVs. They provide rapid assessment of viral titer and impurity analysis for both lentivirus and AAV. Plus, they provide insight into protein capsid ratio and empty/full for AAVs. You will discover how Simple Western can easily fit into your current workflows and adapt to your changing needs, including analysis of newer viral vector modalities like retroviruses.

VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: